Fig. 8From: Autophagy Inhibitor (LY294002) and 5-fluorouracil (5-FU) Combination-Based Nanoliposome for Enhanced Efficacy Against Esophageal Squamous Cell CarcinomaIn vivo antitumor efficacy study on animal model. The formulations free 5-FU, LY, 5-FU + LY and FLNP, respectively, were administered to tumor mice, and efficacy was studied for 20 daysBack to article page